BRAF inhibition (BRAFi) also renders BRAFV600 melanoma cells addicted to oxidative phosphorylation (OXPHOS) by releasing BRAF mediated inhibition of a MITF-PGC1α-OXPHOS pathway12. Here, PPARGC1A is linked to melanoma.